Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum

MLA

Luísa Panadés-de Oliveira, et al. Persistent Asymptomatic or Mild Symptomatic HyperCKemia Due to Mutations in ANO5: The Mildest End of the Anoctaminopathies Spectrum. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....380a1f00d36874638967d6d41ea662ef&authtype=sso&custid=ns315887.

APA

Luísa Panadés-de Oliveira, Laura Bermejo-Guerrero, Aurelio Hernández Lain, Nuria Muelas, Juan J. Vílchez, Diana Cantero Montenegro, Cristina Domínguez-González, Carlos Pablo de Fuenmayor-Fernández de la Hoz, & P Martí. (2020). Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum.

Chicago

Luísa Panadés-de Oliveira, Laura Bermejo-Guerrero, Aurelio Hernández Lain, Nuria Muelas, Juan J. Vílchez, Diana Cantero Montenegro, Cristina Domínguez-González, Carlos Pablo de Fuenmayor-Fernández de la Hoz, and P Martí. 2020. “Persistent Asymptomatic or Mild Symptomatic HyperCKemia Due to Mutations in ANO5: The Mildest End of the Anoctaminopathies Spectrum,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....380a1f00d36874638967d6d41ea662ef&authtype=sso&custid=ns315887.